Should a 5% or 25% albumin solution be used for albumin replacement after large-volume paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Use 25% Albumin for Large-Volume Paracentesis

For albumin replacement after large-volume paracentesis (>5 L), use 20-25% albumin solution at a dose of 6-8 g per liter of ascites removed 1.

Concentration and Dosing

The 2025 AGA Clinical Practice Update explicitly recommends 20-25% intravenous albumin when >5 L of ascites is removed 1. This hyperoncotic formulation (25% albumin) is specifically designed for this indication—it expands plasma volume by 3-4 times the infused volume by drawing fluid from interstitial spaces 2. The FDA labeling confirms that 25% albumin (Plasbumin-25) is indicated for removal of ascitic fluid in cirrhosis patients to support blood volume 2.

Practical Dosing Algorithm:

  • >5 L removed: Give 6-8 g of 25% albumin per liter removed 1
  • <5 L removed: Consider albumin if patient has hypotension, renal insufficiency, or electrolyte abnormalities 1
  • Any volume in ACLF: Give 6-8 g/L regardless of volume 3

Why 25% Over 5%?

The 25% concentration is preferred because:

  • Volume efficiency: Delivers the required albumin dose (typically 50-100 g for most LVPs) in a smaller fluid volume
  • Oncotic effect: The hyperoncotic nature actively pulls fluid from interstitial spaces, which is therapeutically beneficial in cirrhosis 2
  • Practical administration: A 50 g dose requires only 200 mL of 25% albumin versus 1000 mL of 5% albumin

The 5% formulation would be inappropriate here—it's designed for volume replacement in hypovolemic shock when the patient is dehydrated 2. In cirrhosis with ascites, patients have volume overload, not depletion, making the hyperoncotic 25% solution the correct choice.

Evidence Supporting This Approach

The recommendation to use albumin (at this concentration and dose) is supported by strong evidence showing it prevents post-paracentesis circulatory dysfunction (PICD). A 2024 regression discontinuity study demonstrated that albumin infusion at the 5 L threshold reduced serum creatinine by 0.046 mg/dL/day and increased serum sodium by 0.35 mEq/L/day 4. A 2012 meta-analysis of 1,225 patients showed albumin reduced PICD (OR 0.39), hyponatremia (OR 0.58), and mortality (OR 0.64) compared to alternative treatments 5.

Critical Pitfall to Avoid

Do not substitute artificial colloids or saline for albumin in large-volume paracentesis. While some institutions have tried alternatives to reduce costs, the evidence consistently shows albumin is superior. A 2003 RCT found PICD occurred in 33.3% with saline versus 11.4% with albumin (p=0.03) 6. The meta-analysis confirmed albumin outperforms dextran, gelatin, hydroxyethyl starch, and hypertonic saline 5.

Lower Volume Threshold Consideration

Emerging data suggests the 5 L cutoff may be too conservative. The 2024 regression discontinuity study showed worsening renal and sodium parameters after draining just 3 L of fluid 4. For patients with baseline hypotension, renal dysfunction, or electrolyte abnormalities, strongly consider albumin even for 3-5 L removals 1.

Administration Details

Give the albumin after or during the paracentesis procedure. The standard approach is to calculate total dose based on volume removed, then infuse the 25% albumin solution over 1-2 hours following the procedure. Monitor for fluid overload, though this is rare with appropriate dosing 3.

Related Questions

When should albumin be administered after a large‑volume thoracentesis (≥1.5 L) in patients such as the elderly, those with cirrhosis, nephrotic syndrome, severe hypoalbuminemia, or hemodynamic instability?
What volume of ascitic fluid can be drained without albumin infusion?
In a patient with cardiac ascites undergoing large‑volume paracentesis, how should human albumin be administered (dose, infusion rate, and monitoring) while continuing optimal heart‑failure therapy?
What is the role of albumin (human albumin) in large volume paracentesis to prevent hypotension and impaired renal function?
What is the appropriate infusion rate and monitoring for a 25% albumin solution containing 50 g in 200 mL administered over 30 minutes?
What is the appropriate treatment for tinnitus (ringing ears) in a patient with dementia?
What are the contraindications and precautions for using over-the-counter myo‑inositol and D‑chiro‑inositol?
Which ICD‑10‑CM codes should be used to document preventive services for a male partner, including STI screening, HIV testing, hepatitis B vaccination, infectious disease screening, and lifestyle counseling?
What is the significance of reactive mesothelial cells in ascitic fluid and what are the recommended next steps?
Can gabapentin and pregabalin be used together safely, and what dosing guidelines should be followed?
Which laboratory tests should be obtained before initiating and during treatment with valsartan (angiotensin II receptor blocker)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.